Table 3.
Hepatic triglyceride composition
| Group | Fatty acid species (µg/g tissue) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 14:0 | 16:0 | 16:1 | 18:0 | 18:1ω9 | 18:1ω7 | 18:2 | 18:3ω6 | 18:3ω3 | 20:4 | |
| SAL | 12 ± 2 | 195 ± 37 | 24 ± 3 | 62 ± 10 | 214 ± 36 | 46 ± 20 | 111 ± 22 | 15 ± 9 | – | 34 ± 7 |
| GLC | 14 ± 1 | 186 ± 29 | 26 ± 2 | 69 ± 7 | 232 ± 18 | 24 ± 2 | 120 ± 16 | 4 ± 2 | 5 ± 1 | 33 ± 6 |
Samples (n = 6/group) were collected at the end of the clamp period. There were no significant differences between groups for any of the species detected in both groups. The species 18:3ω3 was not detected in the SAL group; in the GLC group, it appeared at the lower limit of detection. 14:0, tetradecanoic acid; 16:0, hexadecanoic acid; 16:1, 9-tetradecenoic acid; 18:0, octadecanoic acid; 18:1ω9, (Z)-octadec-9-enoic (oleic) acid; 18:1ω7, 11-octadecenoic acid; 18:2, 9,12-octadecadienoic (linoleic) acid; 18:3ω6, all-cis-6,9,12-octadecatrienoic acid; 18:3ω3, all-cis-9,12,15-octadecatrienoic (α-linolenic) acid; 20:4, all-cis-5,8,11,14-icosatetraenoic acid.